Corcept Therapeutics, Inc. (CORT) Misses Q1 Loss views by 2c/Share

May 3, 2012 9:01 AM

Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q1 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.

No results found